Association of IL-1β Gene Polymorphism with Prostate Cancer Severity, Prostate Volume, and PSA Levels: A Case-Control Study

IIL-1β polymorphism, particularly the AA genotype, is associated with increased PSA levels, larger prostate volume, and more aggressive prostate cancer phenotypes. These findings underscore the potential of IL-1β genotyping as a biomarker for prostate cancer severity and progression.